Prevalence of potential familial hypercholesteremia (FH) in 54,811 statin-treated patients in clinical practice

Creative Commons License

Catapano A. L., Lautsch D., Tokgozoglu L., Ferrieres J., Horack M., Farnier M., ...Daha Fazla

ATHEROSCLEROSIS, cilt.252, ss.1-8, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 252
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1016/j.atherosclerosis.2016.07.007
  • Dergi Adı: ATHEROSCLEROSIS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1-8
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Background and aims: Familial hypercholesterolemia (FH) is a life-threatening disease, characterized by elevated LDL-C levels and a premature, increased risk of coronary heart disease (CHD) that is globally underdiagnosed. The percentage of patients with possible or probable FH in various countries was examined in the Dyslipidemia International Study (DYSIS).